Drug profile · INN
treosulfan
TRECONDI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
treosulfan (TRECONDI) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN treosulfan
Brand TRECONDI
Route INTRAVENOUS
Formulation POWDER
ATC code L01AB02
Frequently asked questions
What is treosulfan?
treosulfan (TRECONDI) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for treosulfan?
TRECONDI is a marketed brand name for treosulfan. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of treosulfan?
treosulfan has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.